MYCN and chronic myelogenous leukemia, BCR-ABL1 positive: Our results were in accord with the reported study that combination of MTX and JQ1 could synergistically inhibit the proliferation of CML cells both in vitro and in vivo [19], which provided a preliminary basis for the treatment of MYCN-amplified NB with the combination of these two drugs.